Kristine M. Ball's most recent trade in Oruka Therapeutics Inc. was a trade of 17,500 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 2, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Oruka Therapeutics Inc. | Kristine M. Ball | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2025 | 17,500 | 17,500 | - | - | Stock Option (right to buy) | |
| Atreca Inc - Ordinary Shar... | Kristine M. Ball | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2023 | 12,000 | 12,000 | - | - | Stock Option (right to buy) | |
| Atreca Inc - Ordinary Shar... | Kristine M. Ball | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 12,000 | 12,000 | - | - | Stock Option (right to buy) | |
| Atreca Inc - Ordinary Shar... | Kristine M. Ball | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2021 | 12,000 | 12,000 | - | - | Stock Option (right to buy) |